Flovent HFA
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Flovent HFA, covering 2016-02-03 to 2016-02-03. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Compare the Bioavailability Intranasal Administration of 200 and 400 µg or 400 µg Alone of OPTINOSE™ FLUTICASONE With 440 µg of Flovent® HFA (Fluticasone Propionate) Inhalation Aerosol (Part 2) [Phase 1]